AVITA Medical, Inc. (AVH.AX)

2.7700 +0.0800 (+2.97%) At close: 04:10PM AEST

AVITA Medical, Inc.

28159 Avenue Stanford
Suite 220
Valencia, CA 91355
United States
661 367 9170
https://www.avitamedical.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 207

Key executives

Name	Title	Pay	Exercised	Year born
Mr. James M. Corbett	CEO, President & Executive Director	1.78M	N/A	1958
Mr. David O'Toole	Chief Financial Officer	885.62k	N/A	1959
Ms. Donna Shiroma	General Counsel, Chief Compliance Officer & Secretary	1.06M	N/A	1963
Mr. David Fencil	Senior Vice President of Global Operations	N/A	N/A	N/A
Dr. Katie Bush Ph.D.	Senior Vice President of Scientific & Medical Affairs	N/A	N/A	N/A
Ms. Jessica Ekeberg	Investor Relations Executive	N/A	N/A	N/A
Ms. Debbie Garner	Senior Vice President of Global Marketing & Strategy	N/A	N/A	N/A
Mr. Rob Hall	Senior Vice President of Human Resources	N/A	N/A	N/A
Mr. Terry Bromley	Senior Vice President of Global Sales	N/A	N/A	N/A
Dr. Niraj Doshi J.D., P.M.P., Ph.D.	Senior Vice President of Product Development & Program Management	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Corporate governance

AVITA Medical, Inc.’s ISS governance QualityScore as of 1 April 2024 is 6. The pillar scores are Audit: 8; Board: 2; Shareholder rights: 5; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.